搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
University of Waterloo
15 天
Does enforcing fairness mitigate biases caused by subpopulation shift?
Many instances of algorithmic bias are caused by subpopulation shifts. For example, ML models often perform worse on demographic groups that are underrepresented in the training data. In this paper, ...
eLife
7 天
An improved bacterial single-cell RNA-seq reveals biofilm heterogeneity
RiboD-PETRI, a cost-effective, equipment-free plate-based scRNA-seq technique that integrates a unique bacterial rRNA depletion protocol, significantly enhancing mRNA detection rate and revealing ...
MassDevice
6 天
Boston Scientific warns on potential need to replace Accolade pacemaker devices early
The FDA today issued an alert after Boston Scientific warned of the potential need for the early replacement of certain ...
2 天
Aridis Pharmaceuticals continuing to explore ‘multiple paths to monetize’ assets
Aridis Pharmaceuticals (ARDS) announced a corporate update on recent developments. The company said, “The Company continues to diligently ...
3 天
Sangamo: Pipeline Expansion Via Partnership And Internal ST-503 Development
Sangamo Therapeutics, Inc. has groundbreaking treatments for neuropathic pain and Hemophilia A. Click for my updated look at ...
2 天
Optimistic Outlook on Prothena Despite Phase 2b PADOVA Setbacks
Analyst Jason Butler from JMP Securities reiterated a Buy rating on Prothena (PRTA – Research Report) and decreased the price target to $80.00 ...
12 天
Detailed mapping shows how astrocytes change throughout the progression of Alzheimer's disease
Astrocytes are star-shaped glial cells in the central nervous system that support neuronal function, maintain the blood-brain ...
FierceBiotech
4 天
Roche reports failure of Prothena-partnered Parkinson's prospect in phase 2b but highlights ...
Consistent positive trends were seen across multiple secondary and exploratory endpoints, Roche said. Prothena went further ...
9 天
on MSN
What is Red 40 and why hasn't the FDA banned the dye?
The FDA's top food official says the safety of the dye called Red 40 hasn't been assessed in over a decade, despite concerns ...
FierceBiotech
9 天
BeiGene inks $150M deal to follow cancer combo trail blazed by Amgen and Ideaya
BeiGene has struck a $150 million deal to license a cancer candidate from CSPC Zhongqi Pharmaceutical Technology, positioning ...
Zacks Small Cap Research on MSN
20 天
ORMP: Preparations for New Phase 3 Trial Advance, While ORMP Leverages Balance Sheet ...
ORMP READ THE FULL ORMP RESEARCH REPORT Planning Phase 3 Oral Insulin study under revised protocol, new CRO agreement in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈